Tariffs warps trade data
A year after sweeping U.S. tariffs, small American firms say higher import levies are squeezing margins and disrupting planning. At the same time, the New York Times reports that much of the apparent drop in U.S. imports from China reflects paperwork tricks and outright fraud, suggesting tariffs may be inflicting inflationary pain without the promised reshoring. Some multinationals—Bayer among them—say their U.S. forecasts are unaffected because certain goods are covered by tariff caps, but that looks sector‑specific. ( )
Tariffs are supposed to make imported goods look expensive enough that companies build more at home. A year after the Trump administration’s April 2, 2025 “Liberation Day” tariffs, many small American firms say the opposite happened first: their costs jumped, their pricing got harder, and their planning windows got shorter. For a small importer, a tariff works like a surprise fee added at the dock. If a toy, part, or tool used to land for $20 and now lands for $30 or $40, the owner has three choices: raise prices, accept lower margins, or order less inventory and risk empty shelves. That squeeze shows up fastest in businesses that do not have giant purchasing teams or years-long supply contracts. Houston Public Media, in reporting carried by National Public Radio on April 7, 2026, described retailers and other small firms cutting orders and rethinking what they can stock because tariff-driven price jumps made once-routine products harder to sell. One example was especially blunt. Misfit Toys, a Houston store cited in the report, said items it once would have sold for about $25 were now reaching roughly $45, forcing the shop to scale back orders instead of betting on customers accepting the increase. That is the visible part of the tariff story: higher landed costs and thinner margins. The less visible part is that trade data can start lying when the tax gets high enough, because importers and middlemen gain a stronger incentive to change invoices, reroute cargo, or misstate where goods came from. The New York Times reported on April 7, 2026 that much of the apparent drop in United States imports from China does not appear to reflect a clean break in sourcing. Its report said billions of dollars of the change appear tied to accounting gimmicks and outright fraud rather than a simple shift to more American production. That distinction matters because a customs form can change faster than a factory. If a shipment made in China is undervalued, mislabeled, or routed through another country before entering the United States, the trade statistics may show less direct Chinese importing even though the underlying manufacturing base did not really move. There were warning signs before this week’s reporting. Bloomberg reported in February 2026 that the gap between what China said it exported to the United States and what United States Customs and Border Protection recorded as arriving had reached a record $112 billion, a mismatch large enough to suggest widespread evasion, rerouting, or misreporting. That leaves the tariff debate in a more awkward place than either side usually admits. Consumers and small firms can still feel the price pain immediately, while the headline import numbers can overstate how much production has truly shifted out of China or back into the United States. Not every company is reacting the same way. Reuters reported on April 7, 2026 that Bayer’s United States president, Sebastian Guth, said the German drugmaker did not need to change its 2026 forecasts because the United States had committed to honoring a trade deal with the European Union that caps tariffs on most goods from those countries, including medicines, at 15 percent. That looks more like an exception than a template. Bayer sells into a sector with special political attention, and its confidence rests partly on a negotiated cap tied to European Union goods, not on a broad claim that tariffs are easy for most import-dependent businesses to absorb. So the picture one year on is not a clean story of tariffs reviving domestic industry. It is a messier picture in which small firms report real cost pressure, some large companies are shielded by sector-specific deals, and the trade numbers themselves may be warped by fraud serious enough to blur whether reshoring actually happened.
